RCE in NVIDIA Nemoclaw
CVE-2026-65099
NVIDIA NemoClaw for Linux contains a vulnerability in its command-line interface, where an attacker could cause OS command injection. A successful exploit of this vulnerability might lead to code execution, data tampering, information disclosure, and denial of service.
Vulnerability class: Command Injection (OS Command Injection)
Published · last modified .
CVSS v3 metric
CVSS v3 base score 7.8 (High). Vector: CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H.
EPSS exploit prediction
EPSS: 0.013 (70.5th percentile), scored .
Low probability of exploitation in the next 30 days, but still tracked. 70th percentile — 70.5% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.007 · newest: 0.013 · change: +0.006
Affected products
- NVIDIA Nemoclaw — versions 0 to 0.0.1, 0.0.1
Weakness classification (CWE)
References
- nvd.nist.gov/vuln/detail/CVE-2026-65099 (US Government Resource)
- www.cve.org/CVERecord (Third Party Advisory)
- github.com/NVIDIA/product-security/tree/main/2026/5872 (Patch)
Frequently asked questions
- What is CVE-2026-65099?
- CVE-2026-65099 is a high-severity vulnerability in NVIDIA Nemoclaw, classified under OS Command Injection. CVSS score: 7.8/10. Published 2026-08-25.
- How severe is CVE-2026-65099?
- High severity. CVSS v3 base score is 7.8 out of 10.